Biomaterials for Research and Industry

© Fraunhofer ISC

Therapeutic wound patch

The TLC-RT develops synthetic as well as bio-logically based materials, e. g. (μ- and nano-) particles, fibers, coatings for regenerative medicine, tissue engineering and diagnostics. One of the core tasks is to cover the entire value chain, starting from R&D-tasks over process up-scaling, pre-clinic evaluation to the clinical phases.

The TLC-RT provides both the infrastructure for and the experience in processing and manufacturing biomaterials on a pilot scale. Expertise in implementing automated processes for the material synthesis under GMP-compliant conditions and down-stream services as material testing of biocompatibility according to DIN EN ISO 10993 standards and – more advanced – in complex human 3D in-vitro tissue models, which bear a higher predictive power compared to animal tests, completes the supply.

Current activities are focused on biohybrid and biodegradable materials with biofunctionalization, biologized surfaces or controlled drug release properties.


  • Bioresorbable fiber systems
  • Biological carrier systems
  • Biodegradable membranes

In vitro and in vivo

  • Theranostic particle systems
  • Therapy-related diagnostics

Drug delivery

  • Drug-loaded implants
  • Smart coating systems
  • Particular drug carriers

Future technologies

  • Process automation
  • GMP compliant processes
  • Cosmetics
  • Food Technology

Your contact person on site

Sofia Dembski

Contact Press / Media

Dr. Sofia Dembski

Head of Biomaterials

Fraunhofer Translational Center Regenerative Therapies TLC-RT
Neunerplatz 2
97082 Würzburg, Germany

Phone +49 931 4100-516

Fax +49 931 4100-399